Boehringer CEO: Pfizer Is “A Failure”

2 Comments

flunk.jpg

Beating up on Pfizer is becoming a sport - and not just for patients and polticians.

Alessandro Banchi, the ceo of Boehringer Ingelheim, the German drugmaker that’s controlled by the Boehringer family, says the Pfizer model of growing through mergers and acquisitions is “a failure” and that, one day, behemoths such as Pfizer and Glaxo could unravel and be split into smaller companies.

Piling on was Marbod Muff, Boehringer’s finance chief, who crows that: “Pffizer bought first products, operations and they bought companies, and now Pfizer over the past couple of years has been growing negatively, and now they are laying off staff.”

Being independent has its virtues, he adds. “We don’t buy sales,” he sniffs, “We buy R&D.”

What a novel idea.

Read more at Reuters.[tags]Boehringer Ingelheim, Pfizer[/tags]

Jump to comments

Share

Comments

  1. Easy for BI to comment since its management doesn’t have to meet quarterly earnings forecasts.

  2. That’s true. Being independent has its advantages. And hindsight is wonderful, too isn’t it?

Subscribe

RSS Feed

Comments feed for this post only.

Tags

,

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/